{
  "timestamp": "20250103_224023",
  "model": "gpt-4o-mini",
  "interaction_type": "answer_with_enhancement_complete_with_chain",
  "question_id": "43fea185",
  "question_text": "All of the following are true about Nizatidine except",
  "messages": [
    {
      "role": "system",
      "content": "You are a medical expert making decisions based on enhanced information."
    },
    {
      "role": "user",
      "content": "You are a medical expert specializing in the field of Pharmacology.\n                    You are a medical expert determining the final answer.\n\n            ### Instructions:\n            - Use standard medical knowledge as the primary guide.\n            - Consider enhanced information only if it aligns with consensus.\n            - If conflicting or unclear, present the most likely correct answer based on known facts.\n            - It's acceptable to show moderate confidence if the question is complex, but still choose one best answer.\n\n\n                    ### Question\n                    All of the following are true about Nizatidine except\n\n                    ### Options\n                    opa. It is a H2 blocker used in peptic ulcer disease\nopb. It has 100% Bioavailability\nopc. It also enhances gastric emptying\nopd. It can also lead to tachycardia\n\n### Enhanced Information (For Contextual Support):\nNizatidine is indeed an H2 blocker used in the treatment of peptic ulcer disease, which aligns with the consensus (Option A is true). However, its bioavailability is not 100%; it is approximately 70% (Option B is false). Nizatidine does not significantly enhance gastric emptying, as its primary action is to reduce gastric acid secretion (Option C is misleading). Lastly, while tachycardia can occur with H2 blockers, it is not a common side effect of Nizatidine specifically (Option D is also misleading). Therefore, the correct answer is that Nizatidine does not have 100% bioavailability.\n\n                    ### Task:\n                1. Identify the core medical principle and the most likely correct option based on consensus.\n                2. If the evidence is not perfectly clear, pick the best-supported option and explain the reasoning.\n                3. Provide a final analysis and a confidence score (0-100%).\n\n                ### Output Format:\n                {\n                  \"final_analysis\": \"Step-by-step reasoning, prioritizing medical consensus and acknowledging complexity if present.\",\n                  \"answer\": \"Option key (e.g. opa, opb, ...)\",\n                  \"confidence\": A number between 0-100\n                }\n                    "
    }
  ],
  "response": "{\n  \"final_analysis\": \"Nizatidine is an H2 receptor antagonist used primarily for the treatment of peptic ulcer disease, which confirms that option A is true. Regarding bioavailability, Nizatidine has an approximate bioavailability of 70%, not 100%, making option B false. While H2 blockers can influence gastric motility, Nizatidine does not significantly enhance gastric emptying, which makes option C misleading. Lastly, tachycardia is not a common side effect associated specifically with Nizatidine, although it can occur with H2 blockers in general, making option D also misleading. Therefore, the statement that is not true about Nizatidine is that it has 100% bioavailability (option B).\",\n  \"answer\": \"opb\",\n  \"confidence\": 90\n}",
  "metadata": {
    "topic": "Pharmacology",
    "is_multi_choice": true,
    "has_reasoning_chain": true,
    "has_enhanced_info": true,
    "model_config": "gpt-4o-mini",
    "temperature": 0.0
  }
}